Skip to main content

Advertisement

SpringerLink
Log in

Immediate Drug Hypersensitivity

  • Anaphylaxis and Drug Allergy (DA Khan and M Castells, Section Editors)
  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Drug allergy affects a large percentage of the general population. A listed drug allergy can also have broad implications for many aspects of patient care. Here, we will review recent advances in the arena of drug allergies with a focus on antibiotics, monoclonals, NSAIDs, and chemotherapeutics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Ann Allergy Asthma Immunol. 2010;105(4):259–73. doi: 10.1016/j.anai.2010.08.002.

  2. Lee CE, Zembower TR, Fotis MA, Postelnick MJ, Greenberger PA, Peterson LR, et al. The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance. Arch Intern Med. 2000;160(18):2819–22.

    Article  CAS  PubMed  Google Scholar 

  3. Chung G, Wu J, Yeo C, Chan D, Hsu L. Antimicrobial stewardship: a review of prospective audia and feedback systems and an objective evaluation of outcomes. Virulence. 2013:331–7.

  4. Topaz M, Seger D, Slight S, Goss F, Lai K, Wickner P, Blumenthal K, Dhopeshwarkar N, Chang F, Bates D, Zhou L. Rising drug allergy alert overrides in electronic health records: an observational retrospective study of a decade of experience. J Am Med Inform Assoc. 2015.

  5. Macy E, Contreras R. Health care use and serious infection prevalence associated with pencillin “allergy” in hospitalized patients: a cohort study. JACI. 2014;133(3):790–6. Epidemiology study showing effects of having a listed penicillin allergy in medical records.

    Google Scholar 

  6. Macy E. Penicillin allergy: optimizing diagnostic protocols, public health implications, and future reasearch needs. Curr Opin Allergy Clin Immunol. 2015;15(4):308–13.

    Article  CAS  PubMed  Google Scholar 

  7. Blumenthal KG, Shenoy ES, Varughese CA, Hurwitz S, Hooper DC, Benerji A. Impact of a clinical guideline for prescribing antibiotics to inpatients reporting penicillin or cephalosporin allergy. Ann Allergy Asthma Immunol. 2015;115(4):294–300. Outlines a clinical pathway for patients with listed penicillin and cephalosporin allergy for the non-allergist and allergists use.

    Article  PubMed  Google Scholar 

  8. Gaeta F, Valluzzi RL, Alonzi C, Maggioletti M, Caruso C, Romano A. Tolerability of aztreonam and carbapanems in patients with IgE-mediated hypersensitivity to penicillins. J Allergy Clin Immunol. 2015;135(4):972–6.

    Article  CAS  PubMed  Google Scholar 

  9. Romano, A. Cephalosporin allergy: clinical manifestations and diagnosis. In: UpToDate, Post TW, Editor. UpToDate, Waltham, MA. (Accessed on March 25, 2016).

  10. Romano A, Gaeta F, Valluzzi RL, Maggioletti M, Zaffiro A, Caruso C, et al. IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of alternative cephalosporins. J Allergy Clin Immunol. 2015;136(3):685–91.

    Article  CAS  PubMed  Google Scholar 

  11. Blanca-López N, Ariza A, Doña I, Mayorga C, Montañez MI, Garcia-Campos J, et al. Hypersenstivity reactions to fluoroquinolones: analysis of the factors involved. Clin Exp Allergy. 2013;43(5):560–7.

    Article  PubMed  Google Scholar 

  12. Jones SC, Budnitz DS, Sorbello A, Mehta H. US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions. Pharmacoepidemiol Drug Saf. 2013;22(10):1099–106.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Caumes E, Guermonprez G, Lecomte C, Katlama C, Bricaire F. Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus. Arch Dermatol. 1997;133(4):465–9.

    Article  CAS  PubMed  Google Scholar 

  14. Rich JD, Sullivan T, Greineder D, Kazanjian PH. Trimethoprim/sulfamethoxazole incremental dose regimen in human immunodeficiency virus-infected persons. Ann Allergy Asthma Immunol. 1997;79(5):409–14.

    Article  CAS  PubMed  Google Scholar 

  15. Pyle RC, Butterfield JH, Volcheck GW, Podjasek JC, Rank MA, Li JT, et al. Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction. J Allergy Clin Immunol Pract. 2014;2(1):52–8.

    Article  PubMed  Google Scholar 

  16. Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol. 2005;5(4):309–16.

    Article  PubMed  Google Scholar 

  17. Lee-Sarwar K, Johns C, Laidlaw TM, Cahill KN. Tolerance of chronic low-dose aspirin does not preclude aspirin exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2015;3(3):449–451

  18. Cardet JC, White AA, Barrett NA, Feldweg AM, Wickner PG, Savage J, et al. Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2014;2(2):208–13.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Markman M, Kennedy A, Webster K, Elson P, Peterson G, Kulp B, et al. Clinical features of hypersensitivity reactions to carboplatin. J Clin Oncol. 1999;17(4):1141.

    CAS  PubMed  Google Scholar 

  20. Koshiba H, Hosokawa K, Kubo A, Miyagi Y, Oda T, Miyagi Y, et al. Incidence of carboplatin-related hypersensitivity reactions in Japanese patients with gynecologic malignancies. Int J Gynecol Cancer. 2009;19(3):460–5.

    Article  CAS  PubMed  Google Scholar 

  21. Castells MC, Tennant NM, Sloane DE, et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol. 2008;122(3):574–80. Largest patient cohort study assessing the efficacy of a standardized rapid desensitization protocol for HSRs to traditional antineoplastic agents with a focus on carboplatin and paclitaxel.

    Article  CAS  PubMed  Google Scholar 

  22. Brennan PJ, Rodriguez Bouza T, Hsu FI, et al. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment. J Allergy Clin Immunol. 2009;124:1259–66. Largest patient study assessing the efficacy of a standardized rapid desensitization protocol for monoclonal HSRs.

    Article  CAS  PubMed  Google Scholar 

  23. Lee CW, Matulonis UA, Castells MC. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions. Gynecol Oncol. 2004;95(2):370–6.

    Article  CAS  PubMed  Google Scholar 

  24. Lax T, Long A, Banerji A. Skin testing in the evaluation and management of carboplatin-related hypersensitivity reactions. J Allergy Clin Immunol Pract. 2015;3(6):856–62.

    Article  PubMed  Google Scholar 

  25. Markman M, Zanotti K, Peterson G, Kulp B, Webster K, Belinson J. Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity. J Clin Oncol. 2003;21(24):4611–4.

    Article  CAS  PubMed  Google Scholar 

  26. Patil SU, Long AA, Ling M, et al. A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions. J Allergy Clin Immunol. 2012;129:443–7.

    Article  CAS  PubMed  Google Scholar 

  27. Wang AL, Patil SU, Long AA, Banerji A. Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy. Ann Allergy Asthma Immunol. 2015;115(5):422–8.

    Article  CAS  PubMed  Google Scholar 

  28. Dye D, Watkins J. Suspected anaphylactic reaction to Cremophor EL. Br Med J. 1980;280(6228):1353.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Lorenz W, Reimann HJ, Schmal A, Dormann P, Schwarz B, Neugebauer E, et al. Histamine release in dogs by Cremophor E1 and its derivatives: oxethylated oleic acid is the most effective constituent. Agents Actions. 1977;7(1):63–7.

    Article  CAS  PubMed  Google Scholar 

  30. Feldweg AM, Lee CW, Matulonis UA, Castells M. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments. Gynecol Oncol. 2005;96(3):824–9.

    Article  CAS  PubMed  Google Scholar 

  31. Gradishar WJ, Tjulandin S, Davidson N, et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol. 2005;23(31):7794–803.

    Article  CAS  PubMed  Google Scholar 

  32. Prieto García A, Pineda De La Losa F. Immunoglobulin E-mediated severe anaphylaxis to paclitaxel. J Investig Allergol Clin Immunol. 2010;20(2):170–1.

    PubMed  Google Scholar 

  33. Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol. 2004;114:371–6.

    Article  PubMed  Google Scholar 

  34. Picard M, Castells MC. Re-visiting hypersensitivity reactions to taxanes: a comprehensive review. Clin Rev Allergy Immunol. 2015;49(2).

  35. Ha E, Wang W, Wang YJ. Peroxide formation in polysorbate 80 and protein stability. J Pharm Sci. 2002;91(10):2252–64.

    Article  CAS  PubMed  Google Scholar 

  36. Masini E, Planchenault J, Pezziardi F, Gautier P, Gagnol JP. Histamine-releasing properties of Polysorbate 80 in vitro and in vivo: correlation with its hypotensive action in the dog. Agents Actions. 1985;16(6):470–7.

    Article  CAS  PubMed  Google Scholar 

  37. Yang R, Lao QC, Yu HP, Zhang Y, Liu HC, Luan L, et al. Tween-80 and impurity induce anaphylactoid reaction in zebrafish. J Appl Toxicol. 2015;35(3):295–301.

    Article  CAS  PubMed  Google Scholar 

  38. Coors EA, Seybold H, Merk HF, Mahler V. Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions. Ann Allergy Asthma Immunol. 2005;95(6):593–9.

    Article  CAS  PubMed  Google Scholar 

  39. Hong DI, Bankova L, Cahill KN, Kyin T, Castells MC. Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies. Expert Rev Clin Immunol. 2012;8(1):43–52.

    Article  CAS  PubMed  Google Scholar 

  40. Commins SP, Platts-Mills TA. Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant. J Allergy Clin Immunol. 2009;124(4):652–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. van Beers MM, Bardor M. Minimizing immunogenicity of biopharmaceuticals by controlling critical quality attributes of proteins. Biotechnol J. 2012;7(12):1473–84.

    Article  PubMed  Google Scholar 

  42. Commins SP, James HR, Kelly LA, Pochan SL, Workman LJ, Perzanowski MS, Kocan KM, Fahy JV, Nganga LW, Ronmark E, Cooper PJ, Platts-Mills TA.The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactose. J Allergy Clin Immunol. 2011;127(5).

  43. Chung CH, Mirakhur B, Chan E, Le QT, Berlin J, Morse M, et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med. 2008;358(11):1109–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, One Jimmy Fund Way, Smith 636, Boston, MA, 02115, USA

    Paige G. Wickner & David Hong

Authors
  1. Paige G. Wickner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paige G. Wickner.

Ethics declarations

Conflict of Interest

Drs. Wickner and Hong declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Anaphylaxis and Drug Allergy

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wickner, P.G., Hong, D. Immediate Drug Hypersensitivity. Curr Allergy Asthma Rep 16, 49 (2016). https://doi.org/10.1007/s11882-016-0626-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11882-016-0626-5

Keywords

Search

Navigation